The biosense webster, inc.Product analysis lab received the device on 11-nov-2022.The device evaluation was completed on 21-dec-2022.Visual analysis revealed a reddish material inside the pebax and a hole on the surface of the tip area.The device was connected to carto 3 system, and it was not possible to visualize the device in the system.Errors 105 and 106 appeared on the system.The hole at the pebax could be related to the issues found and the issue reported by de customer.All units are inspected prior to leaving the facility as there are functional tests and inspections at control points based on the process flow diagram (pfd) per its part number to avoid this type of damage from leaving the facility.A manufacturing record evaluation was performed for the finished device 30892882l number, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.The instructions for use (ifu) contain the following recommendations: to ensure accurate force readings, verify that the force reading is near zero when the catheter is not in contact with tissue.If the force reading is not near zero when the catheter is not in contact with tissue, perform zeroing.If the force problem persists, replace the catheter cable or the catheter.To prevent damage to the catheter tip, use the insertion tube supplied with the catheter to advance or retract the catheter through the hemostasis valve of the sheath.After insertion, slide the insertion tube back toward the handle.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent an atrial fibrillation (afib) procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the biosense webster inc, (bwi) product analysis lab observed a hole on the surface of the tip area.Initially, it was reported that an error 83, invalid force measurements, was displayed on the carto 3 system when they were about to come on ablation.The bwi representative stated that there were high-force readings displayed on the carto 3 system.The caller noted that the force threshold was set to 50 on the carto 3 system.The cable was replaced with no resolution.When the catheter was replaced, the issue was resolved.No adverse patient consequences were reported.The force high issue was assessed as not mdr reportable the issue is highly detectable when occurring.The potential that it could cause or contribute to a death, serious injury, or other significant adverse event is low.This event is being reported because the biosense webster inc, (bwi) product analysis lab received the device for evaluation and found on 21-dec-2022, that the visual analysis revealed a reddish material inside the pebax and a hole on the surface of the tip area.This finding was assessed as mdr reportable.Therefore, the awareness date for this reportable lab finding is 21-dec-2022.
|